InvestorsHub Logo

H2R

Followers 41
Posts 2230
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: TC_Trader post# 60259

Monday, 05/02/2016 6:04:40 PM

Monday, May 02, 2016 6:04:40 PM

Post# of 732057
Thanks TC Trader! Finally something of interest for the stock.

My favorite part:

The Company has reached conceptual agreement with three different sets of parties, in regard to three different combination treatments, for three different cancers in three different Phase II trials. These involve leading participants in the immunotherapy field. The Company and these parties are now completing the agreements and budgets, and pursuing regulatory approval for the agreed upon trials.

The Company is establishing a Scientific Advisory Board (“SAB”). The Company has reached agreement with the initial members of the SAB, including leading experts in immunotherapy and oncology from both the US and Europe. The initial members are in the process of completing their internal institutional approvals.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News